Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lustberg

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Archives of Internal Medicine|November 20, 2002
Blood lead levels and mortalityMark Lustberg, Ellen Silbergeld
Journal of Medical Case Reports|June 6, 2020
Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case reportJessica N Mezzanotte, I-Sanna Gibbons-Fideler, Konstantin Shilo, et al.
Proceedings of the International Symposium of Human Factors and Ergonomics in Healthcare. International Symposium of Human Factors and Ergonomics in Healthcare|July 27, 2018
A MIXED METHODS APPROACH TO TAILORING EVIDENCE-BASED GUIDANCE FOR ANTIBIOTIC STEWARDSHIP TO ONE MEDICAL SYSTEMEmily S Patterson, Courtney M Dewart, Kurt Stevenson, et al.
Leukemia & Lymphoma|April 22, 2024
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?Gretchen A McNally, Connor M Aossey, Tracy Wiczer, et al.
JAMA|April 4, 2003
Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal womenDenis Nash, Laurence Magder, Mark Lustberg, et al.
Retrovirology : Research and Treatment|February 9, 2016
A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4<sup>+</sup> T-cellsJessica M Mates, Suresh de Silva, Mark Lustberg, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Prediction of Antibiotic Susceptibility for Urinary Tract Infection in a Hospital SettingCourtney Hebert, Yuan Gao, Protiva Rahman, et al.
Antiviral Therapy|July 27, 2024
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohortCourtney N Nichols, Mark Lustberg, Mohammed Mahdee E Sobhanie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
Hospital Pharmacy|September 9, 2022
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency DepartmentElizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Archives of Internal Medicine|November 20, 2002
Blood lead levels and mortalityMark Lustberg, Ellen Silbergeld
Journal of Medical Case Reports|June 6, 2020
Nodular pulmonary deposition disease in a patient with the acquired immunodeficiency syndrome: a case reportJessica N Mezzanotte, I-Sanna Gibbons-Fideler, Konstantin Shilo, et al.
Proceedings of the International Symposium of Human Factors and Ergonomics in Healthcare. International Symposium of Human Factors and Ergonomics in Healthcare|July 27, 2018
A MIXED METHODS APPROACH TO TAILORING EVIDENCE-BASED GUIDANCE FOR ANTIBIOTIC STEWARDSHIP TO ONE MEDICAL SYSTEMEmily S Patterson, Courtney M Dewart, Kurt Stevenson, et al.
Leukemia & Lymphoma|April 22, 2024
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?Gretchen A McNally, Connor M Aossey, Tracy Wiczer, et al.
JAMA|April 4, 2003
Blood lead, blood pressure, and hypertension in perimenopausal and postmenopausal womenDenis Nash, Laurence Magder, Mark Lustberg, et al.
Retrovirology : Research and Treatment|February 9, 2016
A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4<sup>+</sup> T-cellsJessica M Mates, Suresh de Silva, Mark Lustberg, et al.
Antimicrobial Agents and Chemotherapy|April 22, 2020
Prediction of Antibiotic Susceptibility for Urinary Tract Infection in a Hospital SettingCourtney Hebert, Yuan Gao, Protiva Rahman, et al.
Antiviral Therapy|July 27, 2024
Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohortCourtney N Nichols, Mark Lustberg, Mohammed Mahdee E Sobhanie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
Hospital Pharmacy|September 9, 2022
Evidence Based Scarce Resource Allocation During the COVID-19 Pandemic: A Case Study of Bamlanivimab Administration in the Emergency DepartmentElizabeth Rozycki, Ashley Weiner, Carlos Malvestutto, et al.
Pageof 2